Skip to main content

Table 1 Patient characteristics

From: Prognostic role of serum p53 antibodies in lung cancer

  Lung cancer patients Controls
Age (years)   
≤60 47 (23.4%) 27 (50.0%)
>60 154 (76.6%) 27 (50.0%)
Total 201 54
Sex   
Male 157 (78.1%) 27 (50.0%)
Female 44 (21.9%) 27 (50.0%)
Total 201 54
Histological type   
NSCLC   
Adenocarcinoma 79 (39.3%)  
Squamous cell carcinoma 70 (34.8%)  
Bronchioloalveolar carcinoma 6 (3.0%)  
Large cell carcinoma 5 (2.5%)  
Anaplastic carcinoma 19 (9.4%)  
Mixed carcinoma 9 (4.5%)  
SCLC 13 (6.5%)  
Total 201  
NSCLC stage   
I 68 (36.2%)  
II 24 (12.8%)  
III 40 (21.3%)  
IV 45 (23.9%)  
Missing 11 (5.9%)  
Total 188  
NSCLC grade   
G1 4 (2.1%)  
G2 57 (30.3%)  
G3 72 (38.3%)  
Missing 55 (29.3%)  
Total 188